GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lotus Eye Hospital & Institute Ltd (BOM:532998) » Definitions » EBIT

Lotus Eye Hospital & Institute (BOM:532998) EBIT : ₹50.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Lotus Eye Hospital & Institute EBIT?

Lotus Eye Hospital & Institute's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was ₹9.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹50.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Lotus Eye Hospital & Institute's annualized ROC % for the quarter that ended in Dec. 2023 was 3.26%. Lotus Eye Hospital & Institute's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.97%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Lotus Eye Hospital & Institute's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.43%.


Lotus Eye Hospital & Institute EBIT Historical Data

The historical data trend for Lotus Eye Hospital & Institute's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Eye Hospital & Institute EBIT Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.78 15.09 20.49 42.22 57.50

Lotus Eye Hospital & Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.65 9.70 19.41 11.98 9.35

Competitive Comparison of Lotus Eye Hospital & Institute's EBIT

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's EV-to-EBIT falls into.



Lotus Eye Hospital & Institute EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹50.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Eye Hospital & Institute  (BOM:532998) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Lotus Eye Hospital & Institute's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=23.884 * ( 1 - 26.9% )/( (535.223 + 0)/ 1 )
=17.459204/535.223
=3.26 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Lotus Eye Hospital & Institute's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=37.38/( ( (469.022 + max(-3.773, 0)) + (0 + max(0, 0)) )/ 1 )
=37.38/( ( 469.022 + 0 )/ 1 )
=37.38/469.022
=7.97 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(12.488 + 31.02 + 26.083) - (45.528 + 0 + 27.836)
=-3.773

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Lotus Eye Hospital & Institute's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=50.439/1137.444
=4.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Eye Hospital & Institute EBIT Related Terms

Thank you for viewing the detailed overview of Lotus Eye Hospital & Institute's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Eye Hospital & Institute (BOM:532998) Business Description

Traded in Other Exchanges
Address
SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, and contact lens, and optical, of which the majority of the revenue is derived from providing segmmedical services.

Lotus Eye Hospital & Institute (BOM:532998) Headlines

No Headlines